CHAPTER 1: INTRODUCTION

1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.4. Research methodology

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. Key findings of the study
2.2. CXO perspective

CHAPTER 3: MARKET OVERVIEW

3.1. Market definition and scope
3.2. Key findings

3.2.1. Top winning strategies
3.2.2. Top investment pockets

3.3. Top player positioning, 2016
3.4. Market dynamics

3.4.1. Drivers

3.4.1.1. Growth in elderly population and rise in prevalence of chronic diseases
3.4.1.2. Technological advancements in the field of bioimplant
3.4.1.3. Global rise in acceptance of bioimplant
3.4.1.4. Better insurance and reimbursement
3.4.1.5. Increase in government focus on funding R&D initiatives

3.4.2. Restraints

3.4.2.1. High cost of treatment associated with bioimplant
3.4.2.2. Stringent approval process

3.4.3. Opportunities

3.4.3.1. Huge market opportunities in the APAC region and developing countries
3.4.3.2. Increase in development of minimally invasive and non-surgical procedures
3.4.3.3. Rise in awareness amongst patients and increasing preference for a better quality of life

3.4.4. Impact analysis

CHAPTER 4: BIOIMPLANT MARKET BY TYPE

4.1. Overview

4.1.1. Market size and forecast

4.2. Cardiovascular implant

4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by type
4.2.3. Stent

4.2.3.1. Market size and forecast
4.2.3.2. Coronary stent

4.2.3.2.1. Market size and forecast
4.2.3.2.2. Drug-eluting stent

4.2.3.2.2.1. Market size and forecast

4.2.3.2.3. Bare-metal coronary stent

4.2.3.2.3.1. Market size and forecast

4.2.3.2.4. Bioabsorbable stent

4.2.3.2.4.1. Market size and forecast

4.2.3.3. Peripheral stent

4.2.3.3.1. Market size and forecast
4.2.3.3.2. Iliac stent

4.2.3.3.2.1. Market size and forecast

4.2.3.3.3. Femoral-popliteal stent

4.2.3.3.3.1. Market size and forecast

4.2.3.3.4. Renal stent

4.2.3.3.4.1. Market size and forecast

4.2.3.3.5. Carotid stent

4.2.3.3.5.1. Market size and forecast

4.2.3.4. Stent-related implant

4.2.3.4.1. Market size and forecast
4.2.3.4.2. Synthetic graft

4.2.3.4.2.1. Market size and forecast

4.2.3.4.3. Vena cava filter

4.2.3.4.3.1. Market size and forecast

4.2.4. Pacing device

4.2.4.1. Market size and forecast
4.2.4.2. Cardiac resynchronisation therapy (CRT)

4.2.4.2.1. Market size and forecast

4.2.4.3. Implantable cardioverter defibrillators (ICDs)

4.2.4.3.1. Market size and forecast

4.2.4.4. Implantable cardiac pacemaker (ICP)

4.2.4.4.1. Market size and forecast

4.2.5. Structural cardiac implant

4.2.5.1. Market size and forecast
4.2.5.2. Mechanical heart valve

4.2.5.2.1. Market size and forecast

4.2.5.3. Implantable ventricular-assist device (VAD)

4.2.5.3.1. Market size and forecast

4.2.6. Market size and forecast, by region
4.2.7. Market analysis, by country

4.3. Dental and prosthetic implant

4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by type

4.3.2.1. Plate form dental implants

4.3.2.1.1. Market size and forecast

4.3.2.2. Root form dental implants

4.3.2.2.1. Market size and forecast

4.3.3. Market size and forecast, by region
4.3.4. Market analysis, by country

4.4. Orthopedic implant

4.4.1. Key market trends, growth factors and opportunities
4.4.2. Market size and forecast, by type

4.4.2.1. Reconstructive joint replacements

4.4.2.1.1. Market size and forecast
4.4.2.1.2. Knee replacement implants

4.4.2.1.2.1. Market size and forecast

4.4.2.1.3. Hip replacement implants

4.4.2.1.3.1. Market size and forecast

4.4.2.1.4. Extremities

4.4.2.1.4.1. Market size and forecast

4.4.2.2. Orthobiologics

4.4.2.2.1. Market size and forecast

4.4.2.3. Trauma & craniomaxillofacial

4.4.2.3.1. Market size and forecast

4.4.3. Market size and forecast, by region
4.4.4. Market analysis, by country

4.5. Ophthalmic implants

4.5.1. Key market trends, growth factors and opportunities
4.5.2. Market size and forecast, by type

4.5.2.1. Intraocular lens

4.5.2.1.1. Market size and forecast

4.5.2.2. Glaucoma implant

4.5.2.2.1. Market size and forecast

4.5.3. Market size and forecast, by region
4.5.4. Market analysis, by country

4.6. Spinal implants

4.6.1. Key market trends, growth factors and opportunities
4.6.2. Market size and forecast, by type

4.6.2.1. Spinal fusion devices

4.6.2.1.1. Market size and forecast

4.6.2.2. Motion preservation device

4.6.2.2.1. Market size and forecast

4.6.2.3. Vertebral compression fracture (VCF) devices

4.6.2.3.1. Market size and forecast

4.6.2.4. Spinal bone stimulators

4.6.2.4.1. Market size and forecast

4.6.2.5. Spine biologics

4.6.2.5.1. Market size and forecast

4.6.3. Market size and forecast, by region
4.6.4. Market analysis, by country

4.7. Other implants

4.7.1. Key market trends, growth factors and opportunities
4.7.2. Market size and forecast, by region
4.7.3. Market analysis, by country

CHAPTER 5: BIOIMPLANT MARKET, BY MATERIAL

5.1. Overview

5.1.1. Market size and forecast

5.2. Metallic Biomaterials

5.2.1. Market size and forecast, by region
5.2.2. Market analysis, by country

5.3. Ceramic Biomaterial

5.3.1. Market size and forecast, by region
5.3.2. Market analysis, by country

5.4. Polymer Biomaterial

5.4.1. Market size and forecast, by region
5.4.2. Market analysis, by country

5.5. Natural Biomaterials

5.5.1. Market size and forecast, by region
5.5.2. Market analysis, by country

CHAPTER 6: BIOIMPLANT MARKET, BY REGION

6.1. Overview

6.1.1. Market size and forecast

6.2. North America

6.2.1. Key market trends, growth factors, and opportunities
6.2.2. North America market size and forecast, by country

6.2.2.1. U.S. bioimplant market size and forecast

6.2.2.1.1. U.S. bioimplant market size and forecast, by product
6.2.2.1.2. U.S. bioimplant market size and forecast, by material

6.2.2.2. Canada bioimplant market size and forecast

6.2.2.2.1. Canada bioimplant market size and forecast, by product
6.2.2.2.2. Canada bioimplant market size and forecast, by material

6.2.2.3. Mexico bioimplant market size and forecast

6.2.2.3.1. Mexico bioimplant market size and forecast, by product
6.2.2.3.2. Mexico bioimplant market size and forecast, by material

6.2.3. North America market size and forecast, by product
6.2.4. North America market size and forecast, by material

6.3. Europe

6.3.1. Key market trends, growth factors, and opportunities
6.3.2. Europe market size and forecast, by country

6.3.2.1. Germany bioimplant market size and forecast

6.3.2.1.1. Germany bioimplant market size and forecast, by product
6.3.2.1.2. Germany bioimplant market size and forecast, by material

6.3.2.2. France bioimplant market size and forecast

6.3.2.2.1. France bioimplant market size and forecast, by product
6.3.2.2.2. France bioimplant market size and forecast, by material

6.3.2.3. UK bioimplant market size and forecast

6.3.2.3.1. UK bioimplant market size and forecast, by product
6.3.2.3.2. UK bioimplant market size and forecast, by material

6.3.2.4. Italy bioimplant market size and forecast

6.3.2.4.1. Italy bioimplant market size and forecast, by product
6.3.2.4.2. Italy bioimplant market size and forecast, by material

6.3.2.5. Spain bioimplant market size and forecast

6.3.2.5.1. Spain bioimplant market size and forecast, by product
6.3.2.5.2. Spain bioimplant market size and forecast, by material

6.3.2.6. Rest of Europe bioimplant market size and forecast

6.3.2.6.1. Rest of Europe bioimplant market size and forecast, by product
6.3.2.6.2. Rest of Europe bioimplant market size and forecast, by material

6.3.3. Europe market size and forecast, by product
6.3.4. Europe market size and forecast, by material

6.4. Asia-Pacific

6.4.1. Key market trends, growth factors, and opportunities
6.4.2. Asia-Pacific market size and forecast, by country

6.4.2.1. Japan bioimplant market size and forecast

6.4.2.1.1. Japan bioimplant market size and forecast, by product
6.4.2.1.2. Japan bioimplant market size and forecast, by material

6.4.2.2. China bioimplant market size and forecast

6.4.2.2.1. China bioimplant market size and forecast, by product
6.4.2.2.2. China bioimplant market size and forecast, by material

6.4.2.3. India bioimplant market size and forecast

6.4.2.3.1. India bioimplant market size and forecast, by product
6.4.2.3.2. India bioimplant market size and forecast, by material

6.4.2.4. Australia bioimplant market size and forecast

6.4.2.4.1. Australia bioimplant market size and forecast, by product
6.4.2.4.2. Australia bioimplant market size and forecast, by material

6.4.2.5. Rest of Asia-Pacific bioimplant market size and forecast

6.4.2.5.1. Rest of Asia-Pacific bioimplant market size and forecast, by product
6.4.2.5.2. Rest of Asia-Pacific bioimplant market size and forecast, by material

6.4.3. Asia-Pacific market size and forecast, by product
6.4.4. Asia-Pacific market size and forecast, by material

6.5. LAMEA

6.5.1. Key market trends, growth factors, and opportunities
6.5.2. LAMEA market size and forecast, by country

6.5.2.1. Brazil bioimplant market size and forecast

6.5.2.1.1. Brazil bioimplant market size and forecast, by product
6.5.2.1.2. Brazil bioimplant market size and forecast, by material

6.5.2.2. South Africa bioimplant market size and forecast

6.5.2.2.1. South Africa bioimplant market size and forecast, by product
6.5.2.2.2. South Africa bioimplant market size and forecast, by material

6.5.2.3. Saudi Arabia bioimplant market size and forecast

6.5.2.3.1. Saudi Arabia bioimplant market size and forecast, by product
6.5.2.3.2. Saudi Arabia bioimplant market size and forecast, by material

6.5.2.4. Rest of LAMEA bioimplant market size and forecast

6.5.2.4.1. Rest of LAMEA bioimplant market size and forecast, by product
6.5.2.4.2. Rest of LAMEA bioimplant market size and forecast, by material

6.5.3. LAMEA market size and forecast, by product
6.5.4. LAMEA market size and forecast, by material

CHAPTER 7: COMPANY PROFILES

7.1. Abbott Laboratories (St. Jude Medical, Inc.)

7.1.1. Company overview
7.1.2. Company snapshot
7.1.3. Operating business segments
7.1.4. Product portfolio
7.1.5. Business performance
7.1.6. Key strategic moves and developments

7.2. Boston Scientific Corporation

7.2.1. Company overview
7.2.2. Company snapshot
7.2.3. Operating business segments
7.2.4. Product portfolio
7.2.5. Business performance
7.2.6. Key strategic moves and developments

7.3. Dentsply Sirona Inc.

7.3.1. Company overview
7.3.2. Company snapshot
7.3.3. Operating business segments
7.3.4. Product portfolio
7.3.5. Business performance
7.3.6. Key strategic moves and developments

7.4. Johnson & Johnson (Ethicon, Inc.)

7.4.1. Company overview
7.4.2. Company snapshot
7.4.3. Operating business segments
7.4.4. Product portfolio
7.4.5. Business performance
7.4.6. Key strategic moves and developments

7.5. Medtronic plc

7.5.1. Company overview
7.5.2. Company snapshot
7.5.3. Operating business segments
7.5.4. Product portfolio
7.5.5. Business performance
7.5.6. Key strategic moves and developments

7.6. Smith & Nephew plc

7.6.1. Company overview
7.6.2. Company snapshot
7.6.3. Operating business segments
7.6.4. Product portfolio
7.6.5. Business performance

7.7. Stryker Corporation

7.7.1. Company overview
7.7.2. Company snapshot
7.7.3. Operating business segments
7.7.4. Product portfolio
7.7.5. Business performance
7.7.6. Key strategic moves and developments

7.8. Victrex Plc. (Invibio Ltd.)

7.8.1. Company overview
7.8.2. Company snapshot
7.8.3. Operating business segments
7.8.4. Product portfolio
7.8.5. Business performance
7.8.6. Key strategic moves and developments

7.9. Wright Medical Group N.V.

7.9.1. Company overview
7.9.2. Company snapshot
7.9.3. Operating business segments
7.9.4. Product portfolio
7.9.5. Business performance

7.10. Zimmer Biomet Holdings Inc.

7.10.1. Company overview
7.10.2. Company snapshot
7.10.3. Operating business segments
7.10.4. Product portfolio
7.10.5. Business performance
7.10.6. Key strategic moves and developments